SIX •
Healthcare •
Drug Manufacturers - General •
Quote as of 06/22/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeSIX
Market Capitalization847,154 mln
Float889 mln
Earnings Date04/30/2026
EPS
22.23
Exceptional
P / E
40.49
High premium
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-1.67
Likely manipulated
Relative Strength
97
/ 100
Top performer
Debt / Equity
1.39
Elevated leverage
Business Description
Founded in 1876 and based in Indianapolis, Indiana, Eli Lilly and Company is a global pharmaceutical firm that researches, produces, and sells medicines across the United States, Europe, Asia, and beyond. The company's broad portfolio covers treatments for diabetes, obesity, cancer, autoimmune conditions, migraines, and Alzheimer's disease, with well-known products including Mounjaro, Zepbound, Verzenio, and Taltz. Eli Lilly also works alongside other leading pharmaceutical companies, including Boehringer Ingelheim and Roche, to develop and bring additional treatments to patients worldwide.
